Back to Search
Start Over
Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab
- Source :
- Ophthalmic Plastic and Reconstructive Surgery; March-April 2023, Vol. 39 Issue: 2 p150-155, 6p
- Publication Year :
- 2023
-
Abstract
- Despite a national teprotumumab shortage resulting from COVID-19 pandemic, patients who were partially treated with teprotumumab achieve significant reduction in proptosis, clinical activity score, and extraocular muscle restriction and maintain these improvements during short-term interruption.
Details
- Language :
- English
- ISSN :
- 07409303 and 15372677
- Volume :
- 39
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- Ophthalmic Plastic and Reconstructive Surgery
- Publication Type :
- Periodical
- Accession number :
- ejs62432333
- Full Text :
- https://doi.org/10.1097/IOP.0000000000002267